BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15026096)

  • 21. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation.
    Kastner T; Finesmith R; Walsh K
    J Clin Psychopharmacol; 1993 Dec; 13(6):448-51. PubMed ID: 8120159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka.
    Kariyawasam SH; Bandara N; Koralagama A; Senanayake S
    Neurol India; 2004 Jun; 52(2):233-7. PubMed ID: 15269479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the response to antiepileptic drugs: effect of past treatment history.
    Schiller Y; Najjar Y
    Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
    Lossius MI; Hessen E; Mowinckel P; Stavem K; Erikssen J; Gulbrandsen P; Gjerstad L
    Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Repercussion of mental retardation and associated cerebral palsy on skeletal maturation].
    Sánchez-Lastres JM; Eirís-Puñal J; Otero-Cepeda JL; Pavón-Belinchón P; Castro-Gago M
    Rev Neurol; 2002 Feb 1-15; 34(3):236-43. PubMed ID: 12022071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy.
    Aman MG; Paxton JW; Field CJ; Foote SE
    Am J Ment Defic; 1986 May; 90(6):643-50. PubMed ID: 3717220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment with antiepileptics of mentally retarded patients. Experiences from the 1980s a challenge in the 1990s].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):387-91. PubMed ID: 8638270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey.
    Bielen I; Sruk A; Planjar-Prvan M; Cvitanović-Sojat L; Kosicek M; Bergman-Marković B; Baraba R; Butković-Soldo S
    Coll Antropol; 2009 Jun; 33(2):659-63. PubMed ID: 19662794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005.
    Alacqua M; Trifirò G; Spina E; Moretti S; Tari DU; Bramanti P; Caputi AP; Arcoraci V
    Epilepsy Res; 2009 Jul; 85(1):107-13. PubMed ID: 19345564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classifying mental retardation and specific strength and deficit areas in severe and profoundly mentally retarded persons with the MESSIER.
    Matson JL; Dixon DR; Matson ML; Logan JR
    Res Dev Disabil; 2005; 26(1):41-5. PubMed ID: 15590236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Liverpool Adverse Events Profile: relation to AED use and mood.
    Panelli RJ; Kilpatrick C; Moore SM; Matkovic Z; D'Souza WJ; O'Brien TJ
    Epilepsia; 2007 Mar; 48(3):456-63. PubMed ID: 17284301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
    Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
    Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of social skills profiles in intellectually disabled adults with and without ASD.
    Wilkins J; Matson JL
    Behav Modif; 2009 Mar; 33(2):143-55. PubMed ID: 18628363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of switching from Depakene to generic valproic acid on individuals with mental retardation.
    Vadney VJ; Kraushaar KW
    Ment Retard; 1997 Dec; 35(6):468-72. PubMed ID: 9425876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy.
    Camfield P; Camfield C
    Neurology; 2005 Mar; 64(6):973-5. PubMed ID: 15781810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epilepsy and antiepileptic drug use in elderly people as risk factors for dementia.
    Carter MD; Weaver DF; Joudrey HR; Carter AO; Rockwood K
    J Neurol Sci; 2007 Jan; 252(2):169-72. PubMed ID: 17182059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.